Enact Holdings, Inc. filings document the formal disclosures of a U.S. private mortgage insurance company. Form 8-K reports furnish quarterly and annual operating results, press releases, and financial supplements covering mortgage insurance performance, capital sufficiency, insurance in force, book value, and related financial measures.
The company's regulatory filings also cover proxy governance, board and stockholder voting matters, executive compensation, capital-return actions, stock repurchase arrangements involving Genworth Financial, and financing agreements such as its revolving credit facility. These records describe Enact's public-company governance, capital structure, liquidity arrangements, and material events tied to its mortgage insurance operations.
Enact Holdings, Inc. (ACT) reported that EVP and Chief Risk Officer Michael Derstine acquired additional Restricted Stock Units (RSUs) on September 17, 2026 through dividend reinvestment related to existing awards. The acquisitions covered 13, 21, and 35 RSUs, each settling into common stock on a 1:1 basis and vesting in three equal annual installments tied to prior grant schedules beginning on February 16, 2025, February 21, 2026, and February 13, 2027.
Enact Holdings, Inc. (ACT) reported that director Westley V. Thompson acquired 177 Deferred Stock Units on September 17, 2026 as a grant/award. These units were credited under reinvestment terms tied to a dividend and are payable in Common Stock one year after his termination of service as a director. Following this transaction, he holds 35,023.248 Deferred Stock Units directly.
Enact Holdings, Inc. (ACT) reported that director John D. Fisk acquired 177 Deferred Stock Units on September 17, 2026 as a grant/award. These units were credited under reinvestment terms in a director award agreement from a dividend paid at $0.24 per share and are payable in common stock one year after his termination of service as a director. Following this transaction, Fisk directly holds a total of 35,023.248 Deferred Stock Units. No Rule 10b5-1 trading plan is reported for this award.
Enact Holdings, Inc. (ACT) reported that EVP & Chief Operations Officer Brian Gould acquired additional restricted stock units on September 17, 2026 under existing award agreements. Three separate acquisitions covered 10, 17, and 20 restricted stock units, each exchangeable into Enact common stock on a 1:1 basis.
The units were credited pursuant to reinvestment terms tied to a quarterly dividend of $0.24 per share, paid on September 17, 2026. The added units follow the original vesting schedules, converting into common stock in three equal annual installments beginning on February 16, 2025, February 21, 2026, and February 13, 2027, respectively. No Rule 10b5-1 trading plan is reported.
Enact Holdings, Inc. (ACT) reported that director Michael A. Bless acquired 156 Deferred Stock Units on September 17, 2026 as a grant/award. These units were added under the director award agreement through reinvestment of a dividend paid at $0.24 per share.
The Deferred Stock Units are payable in shares of common stock one year after termination of service as a director. Following this transaction, Bless directly holds 30,903.329 Deferred Stock Units, each representing an equivalent number of shares of common stock upon settlement.
Enact Holdings, Inc. (ACT) reported that EVP, General Counsel & Secretary Evan Stolove acquired three small blocks of Restricted Stock Units on September 17, 2026, as additional awards under existing RSU agreements tied to a quarterly dividend.
The acquisitions were for 13, 21, and 25 Restricted Stock Units, each settling into Enact common stock on a 1:1 basis. These RSUs represent dividend reinvestments based on a $0.24 per share dividend paid on September 17, 2026, and vest in three equal annual installments beginning on February 16, 2025, February 21, 2026, and February 13, 2027, respectively. No Rule 10b5-1 trading plan is reported for these transactions.
Enact Holdings, Inc. (ACT) reported that its Controller, James McMullen, acquired multiple small blocks of Restricted Stock Units (RSUs) on September 17, 2026. These RSUs were credited under dividend reinvestment terms tied to a quarterly cash dividend and will settle into common stock on a 1:1 basis as they vest.
The awards include 5 RSUs vesting in three equal annual installments beginning February 16, 2025; 3 RSUs beginning April 1, 2025; 7 RSUs beginning February 21, 2026; 14 RSUs beginning October 1, 2026; and 9 RSUs beginning February 13, 2027. No Rule 10b5-1 trading plan is indicated.
Enact Holdings, Inc. (ACT) reports that major shareholder Genworth Holdings, Inc. sold 687,379 shares of Enact common stock on August 31, 2026 in a transaction priced at $49.396 per share, effected under a Share Repurchase Agreement with Enact. After this sale, Genworth holds 110,390,967 shares, representing approximately 81% of Enact’s outstanding common stock.
Enact Holdings, Inc. (ACT) had a Form 4 filed for executive vice president, general counsel and secretary Evan Stolove, reporting a sale of common stock. On 2026-08-17, Stolove sold 20,024 shares of Enact common stock in a sale classified as an open market or private transaction at a weighted average price of $49.524 per share, with individual trade prices ranging from $49.50 to $49.635 per share. After this transaction, Stolove directly held 32,003 shares of Enact common stock.
ACT filed a notice of proposed sale of common stock. The filing lists 20,024 shares of common stock to be sold through Fidelity Brokerage Services LLC on NASDAQ, with an approximate aggregate market value of $991,687.66, and notes 137,483,671 shares outstanding. The shares come from multiple restricted stock vesting compensation awards between September 2024 and March 2025.